ROCKVILLE, Md.--(BUSINESS WIRE)--Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that it will present at the 12th Annual BIO CEO & Investor Conference on February 9, 2010, at 11:30 a.m. Eastern Standard Time at The Waldorf=Astoria, New York City.
